Gain Therapeutics, Inc. (Nasdaq:GANX)

Health Care/Life Sciences • Biotechnology

CIK 1819411

Company

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never before targeted. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.

Address
4800 Montgomery Lane
Suite 220
Bethesda, Maryland 20814

Employees
32

Stock Info

Close
$1.8500

Day Range
1.5445 - 1.9893

52 Week Range
0.8900 - 4.8000

Average volume
240.6K

Short Interest
462.16K (02/14/25)

% of Float Shorted
1.83%

Market Cap
$49.07M

Revenue
$55.18K

Net Income
-$22.27M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$1.1076

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Khalid Islam

Director
Eric I. Richman

Independent Director
Dov A. Goldstein

Independent Director
Gwen A. Melincoff

Independent Director
Claude Nicaise

Independent Director
Hans-Peter Hasler

Independent Director
Jeffrey Lucero Riley

SEC filings

Date	Form	Event
14 Nov, 2024	8-K
14 Nov, 2024	10-Q
21 Oct, 2024	8-K
8 Oct, 2024	8-K
19 Sep, 2024	S-8
6 Sep, 2024	8-K
6 Sep, 2024	424B5
12 Aug, 2024	4
12 Aug, 2024	4
8 Aug, 2024	10-Q
8 Aug, 2024	8-K
12 Jul, 2024	8-K
9 Jul, 2024	8-K
1 Jul, 2024	FWP
1 Jul, 2024	4
28 Jun, 2024	8-K
26 Jun, 2024	4
26 Jun, 2024	4
26 Jun, 2024	4
26 Jun, 2024	4
26 Jun, 2024	4
26 Jun, 2024	4
26 Jun, 2024	4
25 Jun, 2024	8-K
17 Jun, 2024	424B5
14 Jun, 2024	8-K
13 Jun, 2024	424B5
14 May, 2024	8-K
14 May, 2024	10-Q
26 Apr, 2024	ARS
26 Apr, 2024	DEF 14A
26 Apr, 2024	DEFA14A
8 Apr, 2024	3
8 Apr, 2024	8-K
8 Apr, 2024	4
1 Apr, 2024	4
28 Mar, 2024	4
26 Mar, 2024	8-K
26 Mar, 2024	10-K
25 Mar, 2024	4
25 Mar, 2024	4
22 Feb, 2024	8-K
31 Jan, 2024	8-K
2 Jan, 2024	424B3
29 Dec, 2023	EFFECT
22 Dec, 2023	4
22 Dec, 2023	CORRESP
21 Dec, 2023	UPLOAD
19 Dec, 2023	S-1
14 Dec, 2023	4
24 Nov, 2023	424B5
22 Nov, 2023	8-K
20 Nov, 2023	424B5
17 Nov, 2023	8-K
14 Nov, 2023	8-K
14 Nov, 2023	10-Q
3 Oct, 2023	4
22 Sep, 2023	4
22 Sep, 2023	4
10 Aug, 2023	10-Q
10 Aug, 2023	8-K
5 Jul, 2023	4
26 Jun, 2023	4
26 Jun, 2023	8-K
26 Jun, 2023	4
26 Jun, 2023	4
26 Jun, 2023	4
26 Jun, 2023	4
26 Jun, 2023	4
30 May, 2023	S-8
12 May, 2023	8-K
12 May, 2023	10-Q
28 Apr, 2023	DEF 14A
28 Apr, 2023	ARS
28 Apr, 2023	8-K
28 Apr, 2023	DEFA14A
12 Apr, 2023	3
12 Apr, 2023	8-K
12 Apr, 2023	4
27 Mar, 2023	4
27 Mar, 2023	4
27 Mar, 2023	4
23 Mar, 2023	8-K
23 Mar, 2023	10-K
21 Dec, 2022	3
16 Dec, 2022	8-K
10 Nov, 2022	8-K
10 Nov, 2022	10-Q
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
22 Sep, 2022	4
20 Sep, 2022	8-K	CEO Change
8 Aug, 2022	8-K
8 Aug, 2022	10-Q
19 Jul, 2022	4
19 Jul, 2022	4
15 Jul, 2022	S-8
17 Jun, 2022	8-K
1 Jun, 2022	EFFECT
31 May, 2022	CORRESP
27 May, 2022	4
23 May, 2022	S-3/A
23 May, 2022	4/A
23 May, 2022	4
20 May, 2022	UPLOAD
19 May, 2022	4
18 May, 2022	S-3
16 May, 2022	10-Q
16 May, 2022	8-K
13 May, 2022	DEF 14A
2 May, 2022	10-K/A
21 Apr, 2022	3/A
21 Apr, 2022	4/A
25 Mar, 2022	10-K
24 Mar, 2022	8-K
28 Dec, 2021	8-K
28 Dec, 2021	4
28 Dec, 2021	3
12 Nov, 2021	8-K
12 Nov, 2021	10-Q
20 Oct, 2021	8-K
17 Aug, 2021	4
12 Aug, 2021	10-Q
11 Aug, 2021	8-K
10 May, 2021	8-K
10 May, 2021	10-Q
4 May, 2021	8-K
6 Apr, 2021	S-8
29 Mar, 2021	3
29 Mar, 2021	3
29 Mar, 2021	3
29 Mar, 2021	SC 13G/A
29 Mar, 2021	3
22 Mar, 2021	424B4	IPO completed
22 Mar, 2021	8-K
17 Mar, 2021	3
17 Mar, 2021	EFFECT
17 Mar, 2021	CERT
17 Mar, 2021	8-A12B
17 Mar, 2021	3
17 Mar, 2021	3
17 Mar, 2021	3
17 Mar, 2021	3
16 Mar, 2021	CORRESP
16 Mar, 2021	UPLOAD
15 Mar, 2021	CORRESP
15 Mar, 2021	S-1/A
15 Mar, 2021	CORRESP
15 Mar, 2021	CORRESP
12 Mar, 2021	UPLOAD
10 Mar, 2021	S-1/A
10 Mar, 2021	CORRESP
23 Feb, 2021	UPLOAD
19 Feb, 2021	S-1
19 Feb, 2021	CORRESP
3 Feb, 2021	UPLOAD
29 Jan, 2021	DRSLTR
29 Jan, 2021	DRS/A
19 Jan, 2021	UPLOAD
8 Jan, 2021	DRS/A
8 Jan, 2021	DRSLTR
14 Dec, 2020	UPLOAD
16 Nov, 2020	DRSLTR
16 Nov, 2020	DRS

Last update:2025-03-06 13:27:49.292895

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.